{
  "docId": "019de073-389e-7133-8add-42617e455ecd",
  "docSlug": "35864e552cd13aec6cb8a942f7003b9f",
  "documentTitle": "AbCellera | Results Presentation Deck | 17 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 17,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "thesis_headline",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a gradient-filled callout box to emphasize the proof-of-concept results.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-389e-7133-8add-42617e455ecd/7",
  "deckHref": "/decks/019de073-389e-7133-8add-42617e455ecd",
  "deckJsonHref": "/decks/019de073-389e-7133-8add-42617e455ecd.json",
  "deckAnchorHref": "/decks/019de073-389e-7133-8add-42617e455ecd#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.42,
        "x": 0.5,
        "y": 0.26
      },
      "kind": "callout",
      "text": "CD3 + EGFR BISPECIFIC ANTIBODIES PROOF OF CONCEPT",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7e2140ed-1c68-4cfe-9f86-ac181292fc26",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.38,
        "x": 0.52,
        "y": 0.48
      },
      "kind": "list",
      "text": "Bispecifics induced a wide range of T cell activation. Bispecifics were identified that effectively kill tumor cells with either no or very low cytokine release, suggesting these molecules could overcome key hurdles to getting into the clinic.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e45a65b1-b87d-43fe-855f-7e1b02223e43",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.38,
        "x": 0.08,
        "y": 0.55
      },
      "kind": "paragraph",
      "text": "Our data indicate that our CD3 panel of 200+ unique antibodies bind to a wide variety sites on the CD3 complex and is capable of constructing bispecific antibodies with a very wide range of functional activities - exactly what is needed to build tunable, optimized therapeutic T-cell engagers.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d66d9cac-14fb-4e27-9eaf-a6158a663639",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.08,
        "y": 0.26
      },
      "kind": "title",
      "text": "ADVANCING NEW T-CELL ENGAGER CANCER THERAPIES",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d834491-c6d8-4062-b5ac-493beeda7323",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 6,
      "beatId": "2e5d2b81-8307-4938-84ba-0e67309a2d6c",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "KPI Overview",
      "beatSlug": null,
      "evidence": "The presentation includes multiple slides with KPI overviews, showcasing the company's performance.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 7,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "19a279ed-4e36-45cc-9e86-bf5a6d5da5c5",
      "evidence": "The thesis headline and key messages slides describe the company's technology and potential value.",
      "position": 1,
      "objective": "Explain the company's technology and value proposition",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}